Menu

Funding Ban for Plant Biologist

Olivier Voinnet, who has corrected and retracted several papers, cannot receive Swiss government grants for three years.

Jan 26, 2016
Kerry Grens

FLICKR, INRA DISTA plant biologist whose institution—the Swiss Federal Institute of Technology—found him guilty of scientific misconduct last year is now banned from receiving federal research funding for three years. Retraction Watch today (January 26) reported that the Swiss National Science Foundation stopped Olivier Voinnet’s current funding as well, which totaled about 1.25 million Swiss francs.

Voinnet has amassed seven retractions and 21 corrections, according to Retraction Watch. Just last week (January 22), Science corrected three papers by Voinnet and colleagues.

According to the erratum notice on a 2006 paper on plant antiviral defenses, the corrections stem from “mistakes” in preparing the figures: “The original lab book data provided to the editors of Science showed that these errors did not alter the data in any material way that could be construed to benefit the results and their conclusions. Olivier Voinnet takes the full responsibility for the mistakes.”

Update (January 28): The European Molecular Biology Organization (EMBO) has rescinded an award given to Voinnet, according to writer Leonid Schneider (confirmed by Retraction Watch).

EMBO conducted its own investigation into Voinnet’s publications, finding additional instances of data manipulation beyond those already discussed in the public domain. EMBO director Maria Leptin wrote in a memo to members (via Schneider): “The committee concluded that the manipulation of data in the publications authored by Voinnet was unacceptable for the proper reporting of research and devalued both science in general and the Gold Medal in particular.”

According to Leptin, Voinnet agreed to return the medal.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.